Marksans Pharma Ltd - 524404 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation under Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 201531-08-2021
31-08-2021
Marksans Pharma Ltd - 524404 - Notice Of Book Closure Dates
We wish to inform you that the Register of Members & Share Transfer Books of the Company will remain closed from September 17, 2021 to September 23, 2021 (both days inclusive) for the purpose of Annual General Meeting to be held on September 23, 2021 and payment of dividend, if declared at the Annual General Meeting.30-08-2021
MARKSANS PHARMA LTD. - 524404 - Reg. 34 (1) Annual Report
Attached please find Annual Report of Marksans Pharma Limited for the FY 2020-21.30-08-2021
MARKSANS PHARMA LTD. - 524404 - 29Th Annual General Meeting Scheduled To Be Held On 23Rd September, 2021.
Attached please find the Notice for convening the 29th Annual General Meeting of Marksans Pharma Limited to be held on 23rd September, 2021.30-08-2021
Marksans Pharma Shares Gain On USFDA Approval For Pain Killer Drug
Marksans will manufacture the products at its US Food and Drug Administration (USFDA) approved solid oral dosage facility located at Goa.26-08-2021
MARKSANS PHARMA LTD. - 524404 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Marksans Pharma Limited announces USFDA approval for Acetaminophen Extended-Release Tablets USP, 650 mg (OTC).26-08-2021
MARKSANS PHARMA LTD. - 524404 - Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015
Pursuant to SEBI Circular No. SEBI/HO/ISD/CIR/P/2020/135 dated July 23, 2020, enclosed herewith kindly find reporting of violations related to Code of Conduct framed under SEBI (PIT) Regulations, 2015 by one Designated Person of the Company in the prescribed format.19-08-2021
MARKSANS PHARMA LTD. - 524404 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to Regulation 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 and in compliance with General Circular No.20/2020 dated May 5, 2020 issued by the Ministry of Corporate Affairs, we enclose herewith copies of newspaper advertisement published on 14th August, 2021 in Business Standard (English) and Tarun Bharat (Marathi) newspapers intimating, inter alia, 29th Annual General Meeting to be held on Thursday, 23rd September, 2021 at 9:00 a.m. through VC/ OAVM facility.16-08-2021
Marksans Pharma Ltd - 524404 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclosed herewith Unaudited Financial Results of the Company for the Quarter ended 30th June, 2021 published today i.e. 12th August, 2021 in the Business Standard (English) and Tarun Bharat (Marathi) newspapers.12-08-2021
